v3.26.1
Acquisitions, Dispositions, and Funded Research and Development Arrangements - Acquisition Activity (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 12, 2026
Apr. 20, 2026
Apr. 24, 2026
Apr. 25, 2025
Apr. 26, 2024
Apr. 19, 2026
Business Combination [Line Items]            
Goodwill     $ 42,587 $ 41,737 $ 40,986  
Fair value of contingent consideration     163 81 149  
CathWorks Ltd            
Business Combination [Line Items]            
Ownership percentage           15.00%
Gain on investments     45      
Business combinations            
Business Combination [Line Items]            
Total purchase price       128 335  
Assets acquired       159 338  
Liabilities assumed       31 3  
Goodwill       108 131  
Fair value of contingent consideration       20 30  
Goodwill, net of tax         51  
Goodwill, non deductible amount         $ 80  
Business combinations | Technology            
Business Combination [Line Items]            
Estimated useful life         10 years  
Other intangible assets         $ 29  
Business combinations | IPR&D            
Business Combination [Line Items]            
Indefinite-lived intangible assets       $ 50 $ 150  
CathWorks Ltd            
Business Combination [Line Items]            
Business combination, voting equity interest acquired, percentage   85.00%        
Revenue since acquisition     0      
Net income (loss) since acquisition     $ 0      
Cash consideration paid at closing   $ 410        
Total purchase price   525        
Assets acquired   784        
Liabilities assumed   66        
Goodwill   555        
Fair value of contingent consideration   115        
Other intangible assets   $ 200        
CathWorks Ltd | Technology            
Business Combination [Line Items]            
Estimated useful life   10 years        
Scientia Vascular (Scientia) | Subsequent Event            
Business Combination [Line Items]            
Regulatory based contingent consideration $ 375          
Total purchase price $ 550